Trethera Selected for 2026–2027 National Cancer Institute Investor Showcase
Trethera was selected as a company for the National Cancer Institute’s 2026–2027 Investor Showcase.
Related stories
PAG to Acquire 51% Stake in Evergrande Property Services for $514 Million
PAG will acquire a 51% stake for HK$4.03 billion ($513.64 million), Evergrande Property Services said. The offer values 5.52 billion shares at HK$0.8359 each, a 29% discount to the
M impact | EQUITY | Oct 30, 2026, 12:19 AM UTC
Bayer Wins Trial in Roundup Cancer Cases
Bayer won a trial involving allegations that Roundup caused cancer in three women.
M impact | EQUITY | Oct 30, 2026, 12:08 AM UTC
Advantest shares fall 5.6%
M impact | EQUITY | Oct 30, 2026, 12:07 AM UTC
Japan's Nikkei Share Average Falls 1.1%
M impact | EQUITY | Oct 30, 2026, 12:06 AM UTC
Hammond Power Solutions Reports Quarterly Results
The company reported results for the quarter ended September 30; no financial figures were provided.
M impact | EQUITY | Oct 30, 2026, 12:06 AM UTC
Tokyo Electron Shares Fall 4%
M impact | EQUITY | Oct 30, 2026, 12:05 AM UTC